Loncar China Biopharma ETF (CHNA) Short Interest Ratio & Short Volume

Short interest is the volume of Loncar China Biopharma ETF shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 500 shares of CHNA short. Learn More on Loncar China Biopharma ETF's current short interest.

Here is how the short interest of companies compare to Loncar China Biopharma ETF: ProShares UltraShort Nasdaq Biotechnology (4.44%), JPMorgan Healthcare Leaders ETF (0.07%), First Trust Nasdaq Pharmaceuticals ETF (0.05%), Invesco Nasdaq Biotechnology ETF (0.14%), ProShares Ultra Nasdaq Biotechnology (1.22%), Invesco Dorsey Wright Healthcare Momentum ETF (0.21%), VanEck Biotech ETF (0.49%), VanEck Pharmaceutical ETF (41.19%), and iShares Biotechnology ETF (23.58%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.27 billion), Charter Communications, Inc. ($2.66 billion), TC Energy Co. ($2.53 billion), Chesapeake Energy Co. ($1.86 billion), Coinbase Global, Inc. ($1.83 billion), Lucid Group, Inc. ($1.78 billion), T. Rowe Price Group, Inc. ($1.77 billion), Rivian Automotive, Inc. ($1.69 billion), Zoom Video Communications, Inc. ($1.35 billion), and Williams-Sonoma, Inc. ($1.35 billion). View all of the most shorted stocks.

Short selling CHNA is an investing strategy that aims to generate trading profit from Loncar China Biopharma ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Loncar China Biopharma ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CHNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHNA, twice per month. The most recent reporting period available is September, 30 2022.